Gossamer Bio Other Operating Expenses (Quarterly) Insights

Gossamer Bio, Inc. (GOSS)

2.495 -0.06 (-2.16%) USD | NASDAQ | Jan 15, 11:41

View Other Operating Expenses (Quarterly) for GOSS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
XOMA Royalty Corp.	Upgrade
Rezolute, Inc.	--
Axsome Therapeutics, Inc.	--
Crinetics Pharmaceuticals, Inc.	--